Clincosm LogoSign in Get a demo

Unspecified Adult Solid Tumor, Protocol Specific

Showing NaN - NaN of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Boston, New York (gemcitabine HCl, alvocidib, pharmacological study)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • gemcitabine hydrochloride
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jul 1, 2013

Metastatic Cancer, Solid Tumor Trial in United States (polifeprosan 20 with carmustine implant, conventional surgery)

Completed
  • Metastatic Cancer
  • Unspecified Adult Solid Tumor, Protocol Specific
  • polifeprosan 20 with carmustine implant
  • conventional surgery
  • Birmingham, Alabama
  • +10 more
Jun 20, 2013

Lymphoma, Small Intestine Cancer, Solid Tumor Trial in United States (irinotecan HCl)

Completed
  • Lymphoma
  • +2 more
  • irinotecan hydrochloride
  • Birmingham, Alabama
  • +44 more
Mar 19, 2013

Solid Tumor Trial in Boston (alvocidib, gemcitabine HCl)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Boston, Massachusetts
  • +1 more
Feb 27, 2013

Hypercalcemia of Malignancy, Lung Cancer, Metastatic Cancer Trial in United States (zoledronic acid, quality-of-life assessment)

Completed
  • Hypercalcemia of Malignancy
  • +4 more
  • zoledronic acid
  • quality-of-life assessment
  • Birmingham, Alabama
  • +54 more
Feb 20, 2013

Solid Tumor Trial in Boston (recombinant interleukin-12)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • recombinant interleukin-12
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Feb 8, 2013

Solid Tumor Trial in Boston (recombinant interleukin-12, aldesleukin, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • recombinant interleukin-12
  • +2 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 31, 2013

Solid Tumor Trial in Boston (SarCNU, pharmacological study, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 31, 2013

Solid Tumor Trial in Boston (BMS-214662, laboratory biomarker analysis, pharmacological study)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 31, 2013

Solid Tumor Trial in Boston (KRN5500, pharmacological study)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 10, 2013

Lymphoma, Small Intestine Cancer, Solid Tumor Trial in Boston, New York (bortezomib)

Completed
  • Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +4 more
Nov 8, 2012

Bone Marrow Suppression, Fever, Sweats, and Hot Flashes, Infection Trial in Worldwide (piperacillin sodium,

Completed
  • Bone Marrow Suppression
  • +8 more
  • piperacillin sodium
  • +3 more
  • Baltimore, Maryland
  • +27 more
Sep 20, 2012